| Inflammatory bowel disease: clinical aspects and treatments M Fakhoury, R Negrulj, A Mooranian, H Al-Salami Journal of inflammation research, 113-120, 2014 | 635 | 2014 |
| Microglia and astrocytes in Alzheimer's disease: implications for therapy M Fakhoury Current neuropharmacology 16 (5), 508-518, 2018 | 493 | 2018 |
| Autistic spectrum disorders: A review of clinical features, theories and diagnosis M Fakhoury International journal of developmental neuroscience 43, 70-77, 2015 | 331 | 2015 |
| Revisiting the serotonin hypothesis: implications for major depressive disorders M Fakhoury Molecular neurobiology 53 (5), 2778-2786, 2016 | 262 | 2016 |
| Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases M Fakhoury Neurodegenerative Diseases 15 (2), 63-69, 2015 | 122 | 2015 |
| Spinal cord injury: overview of experimental approaches used to restore locomotor activity M Fakhoury Reviews in the Neurosciences 26 (4), 397-405, 2015 | 119 | 2015 |
| The habenula in psychiatric disorders: more than three decades of translational investigation M Fakhoury Neuroscience & Biobehavioral Reviews 83, 721-735, 2017 | 94 | 2017 |
| Role of the endocannabinoid system in the pathophysiology of schizophrenia M Fakhoury Molecular neurobiology 54 (1), 768-778, 2017 | 85 | 2017 |
| Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol A Mooranian, R Negrulj, N Chen-Tan, HS Al-Sallami, Z Fang, TK Mukkur, ... Drug design, development and therapy, 1221-1230, 2014 | 78 | 2014 |
| Artificial intelligence in psychiatry M Fakhoury Frontiers in psychiatry: artificial intelligence, precision medicine, and …, 2019 | 71 | 2019 |
| New insights into the neurobiological mechanisms of major depressive disorders M Fakhoury General hospital psychiatry 37 (2), 172-177, 2015 | 68 | 2015 |
| Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes R Negrulj, A Mooranian, N Chen-Tan, HS Al-Sallami, M Mikov, ... Artificial cells, nanomedicine, and biotechnology 44 (5), 1290-1297, 2016 | 61 | 2016 |
| Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment A Mooranian, R Negrulj, N Chen-Tan, M Fakhoury, F Arfuso, F Jones, ... Artificial cells, nanomedicine, and biotechnology 44 (2), 588-595, 2016 | 58 | 2016 |
| Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study A Mooranian, R Negrulj, N Chen-Tan, HS Al-Sallami, Z Fang, T Mukkur, ... Drug design, development and therapy, 1003-1012, 2014 | 58 | 2014 |
| Drug delivery approaches for the treatment of glioblastoma multiforme M Fakhoury Artificial cells, nanomedicine, and biotechnology 44 (6), 1365-1373, 2016 | 56 | 2016 |
| Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes A Mooranian, R Negrulj, HS Al-Sallami, Z Fang, M Mikov, ... Aaps Pharmscitech 16, 45-52, 2015 | 52 | 2015 |
| The lateral hypothalamus: an uncharted territory for processing peripheral neurogenic inflammation M Fakhoury, I Salman, W Najjar, G Merhej, N Lawand Frontiers in neuroscience 14, 101, 2020 | 51 | 2020 |
| Could cannabidiol be used as an alternative to antipsychotics? M Fakhoury Journal of psychiatric research 80, 14-21, 2016 | 50 | 2016 |
| Immune-mediated processes in neurodegeneration: where do we stand? M Fakhoury Journal of neurology 263, 1683-1701, 2016 | 49 | 2016 |
| Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment A Mooranian, R Negrulj, HS Al-Sallami, Z Fang, M Mikov, ... Journal of microencapsulation 32 (2), 151-156, 2015 | 46 | 2015 |